Jim Cornall

biotech

PDS Biotech seeking expedited approval pathway for head and neck cancer drug

biotech

Study identifies which patients benefit most from new schizophrenia drug

biotech

Mechanism behind overactive immune cells revealed​

biotech

Investigational treatment of autosomal dominant polycystic kidney disease receives orphan drug designation

biotech

World’s first gene-editing therapy for hyperlipidemia

biotech

Positive results for Lilly obesity drug

biotech

“Foundational moment for in vivo cell therapy”

biotech

Cooperative motor proteins kill cancer cells when dual-inhibited